Immunology

Just another common cold virus? Modeling SARS-CoV-2’s future fade

Jan. 12, 2021

Emory ranks 5th among U.S. universities for infectious diseases program

Jan. 12, 2021

Emory begins Phase 3 study of Novavax COVID-19 vaccine

Dec. 29, 2020

Emory Healthcare administers first COVID-19 vaccinations to its frontline health care workers

Dec. 17, 2020

Engineered 'stealth bomber' virus could be new weapon against metastatic cancer

Nov. 30, 2020

Emory begins advanced stage clinical trial for another COVID-19 vaccine

Oct. 29, 2020

Georgia Research Alliance supporting two new scholars at Emory

Oct. 22, 2020

NCI awarding Emory $9.9 million to study cancer, autoimmune intersection with COVID-19

Oct. 15, 2020

Monoclonal antibodies for COVID-19: Emory experts explain experimental treatment

Oct. 13, 2020

Immune cell activation in severe COVID-19 resembles lupus

Oct. 7, 2020

High antiviral antibody levels may herald pediatric COVID-19 complication

Sep. 8, 2020

Emory immunologist Max Cooper to deliver 2020 Distinguished Faculty Lecture

Sep. 2, 2020

Seasonal flu vaccinations don’t 'stick' long-term in bone marrow

Aug. 13, 2020

COVID-19 vaccine tested at Emory is safe, generates immune response, early results show

July 14, 2020

Vaccine additives can enhance immune flexibility – implications for flu and SARS-CoV-2

July 13, 2020

COVID-19 research: Emory’s work spans the gamut, from bench to bedside

June 12, 2020

Research roundup: Recent grants and publications for Emory faculty and staff

May 15, 2020

Winship treats first lung cancer patient with T-cell receptor therapy

May 11, 2020

Emory launches study on COVID-19 immune responses

April 30, 2020

Research roundup: Recent grants and publications for Emory faculty and staff

April 22, 2020

How immunologist Max Cooper may have saved your life

Sep. 9, 2019